摘要
吡美莫司是一类新型局部免疫抑制剂,主要用于特应性皮炎的治疗.近年来该药的应用范围有所扩大,可被广泛应用于多种湿疹皮炎类皮肤病,如特应性皮炎、湿疹、接触性皮炎、口周皮炎等.多项临床研究均表明,每天2次外用吡美莫司可达到良好的疗效,且不良反应小,提示该药在治疗湿疹皮炎类疾病中有着广阔的应用前景.
As a new type of topical immunosuppressive agent,pimecrolimus is mainly used in the treatment of atopic dermatitis.Recently,the application range of pimecrolimus has been broadened and it has been widely used in many allergic dermatoses,such as atopic dermatitis,eczema,contact dermatitis,perioral dermatitis,et al.Several clinical studies have suggested that topical pimecrolimus twice daily has favorable effect with few side effects.Therefore,pimecrolimus may have a promising future in the treatment of allergic dermatoses such as dermatitis and eczema.
出处
《国际皮肤性病学杂志》
2011年第4期231-233,共3页
International Journal of Dermatology and Venereology
关键词
特应性皮炎
湿疹
吡美莫司
Atopic dermatitis
Eczema
Pimecrolimus
